Moderna’s new lower-dose COVID-19 vaccine approved by FDA

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup